ea0041ep557 | Diabetes therapy | ECE2016
de Adana Navas M Soledad Ruiz
, Dominguez-Lopez Marta
, Rubio Eleazara
, Rodriguez Natalia Colomo
, Cardona Isabel
, Tapia M Jose
, Morillas Virgina
, Gonzlez Inmaculada
, Rojo Gemma
Aims: There are few data comparing oxidative stress markers in CSII versus MDI/G We compared after randomization CSII (Continuous subcutaneous insulin infusion) vs MDI/G therapy (multiple doses of insulin with glargine) in DM1 people previously optimized at MDI/G being the primary objective assessment of metabolic control and oxidative stress.Assess oxidative stress and metabolic control in patients with type 1 diabetes (T1D) after randomization in CSII ...